6.
Bjornsson E, Olsson R
. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005; 42(2):481-9.
DOI: 10.1002/hep.20800.
View
7.
Larkin J, Chiarion-Sileni V, Gonzalez R, Grob J, Cowey C, Lao C
. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015; 373(1):23-34.
PMC: 5698905.
DOI: 10.1056/NEJMoa1504030.
View
8.
Chalasani N, Maddur H, Russo M, Wong R, Reddy K
. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol. 2021; 116(5):878-898.
DOI: 10.14309/ajg.0000000000001259.
View
9.
Bjornsson E
. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol. 2017; 52(6-7):617-623.
DOI: 10.1080/00365521.2017.1291719.
View
10.
Varma S, Nathanson J, Dowlatshahi M, Del Portillo A, Ramirez I, Garcia-Carrasquillo R
. Doxycycline-induced cholestatic liver injury. Clin J Gastroenterol. 2021; 14(5):1503-1510.
DOI: 10.1007/s12328-021-01475-7.
View
11.
Bjornsson H, Bjornsson E
. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med. 2021; 97:26-31.
DOI: 10.1016/j.ejim.2021.10.035.
View
12.
Parker M, McGill N
. Minocycline-associated polyarteritis nodosa and self-limiting hepatitis: a reminder of a potentially re-emerging culprit in drug-induced autoimmune syndromes. Scand J Rheumatol. 2018; 47(6):507-508.
DOI: 10.1080/03009742.2017.1416669.
View
13.
Bjornsson E, Andrade R
. Long-term sequelae of drug-induced liver injury. J Hepatol. 2021; 76(2):435-445.
DOI: 10.1016/j.jhep.2021.10.011.
View
14.
Andrade R, Chalasani N, Bjornsson E, Suzuki A, Kullak-Ublick G, Watkins P
. Drug-induced liver injury. Nat Rev Dis Primers. 2019; 5(1):58.
DOI: 10.1038/s41572-019-0105-0.
View
15.
Chu H, Ai Y, Cheng Z, Yang L, Hou X
. Contribution of gut microbiota to drug-induced liver injury. Hepatobiliary Pancreat Dis Int. 2023; 22(5):458-465.
DOI: 10.1016/j.hbpd.2023.06.008.
View
16.
Nabi T, Nabi S, Rafiq N, Shah A
. Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study. Saudi J Gastroenterol. 2017; 23(3):169-175.
PMC: 5470376.
DOI: 10.4103/1319-3767.207711.
View
17.
Clinton J, Kiparizoska S, Aggarwal S, Woo S, Davis W, Lewis J
. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Saf. 2021; 44(11):1125-1149.
PMC: 8447115.
DOI: 10.1007/s40264-021-01109-4.
View
18.
Efe C, Kulkarni A, Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M
. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology. 2022; 76(6):1576-1586.
PMC: 9348326.
DOI: 10.1002/hep.32572.
View
19.
Bjornsson E, Bergmann O, Bjornsson H, Kvaran R, Olafsson S
. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013; 144(7):1419-25, 1425.e1-3.
DOI: 10.1053/j.gastro.2013.02.006.
View
20.
Remash D, Prince D, McKenzie C, Strasser S, Kao S, Liu K
. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol. 2021; 27(32):5376-5391.
PMC: 8409159.
DOI: 10.3748/wjg.v27.i32.5376.
View